Lub luag haujlwm tseem ceeb ntawmEpitalon ntsiav tshuaj(tseem hu ua Epithalon lossis AEDG) tsis ncaj qha rau cov ntshav coagulation system lossis platelet activation tab sis txo qhov kev pheej hmoo ntawm thrombosis los ntawm ntau qhov sib txawv, kev tswj hwm ntawm homeostasis. Nws txhawb kev kho cov kab mob endothelial, txhim kho kev ua haujlwm ntawm nitric oxide (NO) synthase, thiab ua kom cov bioavailability ntawm NO, yog li tswj vasodilation, inhibiting vascular inflammatory teb, thiab txo cov kev qhia ntawm endothelial adhesion molecules. Cov nyhuv no pab tswj kev ncaj ncees ntawm phab ntsa vascular thiab nws cov phenotype anticoagulant, tiv thaiv kev pib ntawm pathological thrombosis ntawm nws qhov chaw.
Cov tshuaj tsis yog ib hom tshuaj antithrombotic; Hloov chaw, nws txo qis tag nrho cov kev pheej hmoo ntawm thrombosis los ntawm kev rov ua kom lub cev muaj zog, ncua kev laus ntawm cov hlab ntsha, thiab txhim kho lub peev xwm hloov tau ntawm tag nrho cov kab ke. Nws cov nyhuv sawv cev rau lub hauv paus thiab holistic mus kom ze rau kev tswj hwm homeostasis, ua tiav cov txheej txheem ntawm cov tshuaj uas cuam tshuam ncaj qha rau hauv coagulation cascade. Cov yam ntxwv tshwj xeeb no tseem ua rau nws muaj txiaj ntsig tseem ceeb hauv thaj chaw tiv thaiv- laus thiab hnub nyoog- cuam tshuam txog kev tiv thaiv kab mob plawv thiab tswj.
Peb Cov Khoom Muag Khoom
Epitalon COA
Epitalon qeeb endothelial cell aging thiab txo qhov kev pheej hmoo ntawm thrombosis
Qhov no yog ib qho hluavtaws tetrapeptide. Nws lub peev xwm los txo qhov kev pheej hmoo ntawm thrombosis tsis cuam tshuam ncaj qha rau ntawm coagulation yam lossis cov txheej txheem tseem ceeb ntawm platelet activation. Hloov chaw, nws ua haujlwm los ntawm kev tsis ncaj, ntau- lub hom phiaj, thiab ntau- kev tswj hwm cov kauj ruam, tsim kom muaj kev ruaj khov los tiv thaiv- thrombotic ib puag ncig los ntawm kev tiv thaiv vascular endothelial muaj nuj nqi, optimizing hemorheology, inhibiting oxidative stress thiab o, thiab modulating neuroendocrine tshuav nyiaj li cas.
Lub vascular endothelium, raws li ib qho tseem ceeb barrier, tswj kev ncaj ncees los tiv thaiv thrombosis. Kev puas tsuaj endothelial nthuav tawm collagen, ua rau platelet adhesion thiab coagulation.Epitalon ntsiav tshuajactivates telomerase thim rov qab transcriptase (TERT), txuas ntxiv endothelial cell telomeres kom ncua kev laus thiab apoptosis. Qhov no khaws cia endothelial proliferation thiab ciaj sia taus, txo subendothelial matrix raug thiab thaiv thrombosis pib. Nws kuj inhibits apoptosis txoj hauv kev los ntawm kev txo qis pro-apoptotic proteins (xws li, Bax, Caspase-3) thiab upregulating anti-apoptotic Bcl-2, mitigating oxidative thiab metabolic stress kom tswj vascular smoothness.
Nws boosts endothelial nitric oxide synthase (eNOS) kev ua si thiab nitric oxide (NO) bioavailability ntawm PI3K / Akt txoj kev ua kom, txhim kho TSIS synthesis thaum txo nws cov inactivation los ntawm ROS. Tsis tas li ntawd, nws upregulates prostacyclin (PGI₂) thiab thrombomodulin (TM) ntau lawm. PGI₂ inhibits platelet aggregation thiab dilates hlab ntsha, synergizing nrog NO. TM khi thrombin kom qhib cov protein C, degrading yam Va thiab VIIIa, yog li suppressing coagulation amplification.
Txo tag nrho cov ntshav viscosity thiab plasma viscosity
- Txo Erythrocyte Aggregation: Nyob rau hauv cov xwm txheej pathological, erythrocytes zoo li sib sau ua "rouleaux" vim muaj kev hloov pauv ntawm cov nqi saum npoo, ua rau cov ntshav ntws tawm. Nws tuaj yeem hloov kho cov phospholipid muaj pes tsawg leeg thiab them nqi faib ntawm erythrocyte daim nyias nyias, txo cov kev sib txuas ntawm cov cellular, dispersing erythrocyte aggregates, thiab txo cov ntshav viscosity.
- Txhim kho Erythrocyte Deformability: Erythrocyte deformability yog qhov tseem ceeb rau lawv txoj kev hla ntawm cov hlab ntsha. Kev laus lossis oxidative kev nyuaj siab tuaj yeem ua rau erythrocyte stiffening thiab txo deformability. Qhov no tiv thaiv erythrocyte daim nyias nyias kev ncaj ncees los ntawm nws cov teebmeem antioxidant, tswj lawv cov yoog raws, ua kom cov ntshav khiav hauv microcirculation, thiab tiv thaiv stasis.
Inhibiting Ntau Platelet Activation thiab Aggregation.Platelet activation yog ib kauj ruam tseem ceeb hauv thrombosis, tsav los ntawm agonists xws li ADP, thromboxane A₂ (TXA₂), thiab collagen. ThaumEpitalon ntsiav tshuajtsis ncaj qha thaiv platelet receptors, nws tsis ncaj qha inhibits platelet activation los ntawm cov txheej txheem hauv qab no:
- Txo cov tiam ntawm cov pa oxygen reactive (ROS) nyob rau hauv platelets, yog li inhibiting kev tso tawm ntawm pro-aggregatory mediators xws li ADP thiab TXA₂.
- Kev txo qis ntawm P-selectin ntawm platelet nto, uas txo cov platelet adhesion thiab cross- txuas nrog endothelial hlwb thiab leukocytes, tiv thaiv kev tsim ntawm platelet- leukocyte aggregates (ib feem tseem ceeb ntawm thrombi).
Kev ntxhov siab oxidative thiab mob ntev yog cov hauv paus pathological uas ua rau vascular endothelial puas, platelet activation, thiab coagulation activation. Ob leeg txhawb ib leeg, ua rau lub voj voog tsis zoo ntawm "mob-oxidative kev nyuaj siab-thrombosis." Nws rhuav tshem lub voj voog no los ntawm kev hloov kho dual.
Nws txhawb kev ua haujlwm ntawm superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), thiab catalase (CAT), txhim kho lub peev xwm ntawm tes kom tshem tawm cov pa oxygen reactive (ROS). ROS tua endothelial cell membrane lipids, proteins, thiab DNA, ua rau endothelial puas, thaum tseem ncaj qha activating platelets thiab coagulation factor X, txhawb thrombus tsim. Tsis tas li ntawd, Epitalon txo qis kev tsim cov lipid peroxidation cov khoom xws li malondialdehyde (MDA), tiv thaiv daim nyias nyias ntawm vascular endothelial hlwb thiab erythrocytes thiab tswj lawv cov kev ua haujlwm ib txwm muaj.
Epitalon inhibits kev tso tawm ntawm pro-inflammatory cytokines thiab txo cov theem ntawm cov qog necrosis factor- (TNF-), interleukin-6 (IL-6), thiab C-reactive protein (CRP) hauv cov ntshav. Cov inflammatory yam cuam tshuam ncaj qha ua rau cov hlwb endothelial, ua rau kev qhia ntawm adhesion molecules (xws li ICAM-1 thiab VCAM-1) ntawm endothelial hlwb, txhawb leukocyte adhesion thiab infiltration, thiab exacerbate vascular phab ntsa. Lawv kuj txhawb lub siab los ua kom mob hnyav- theem teb cov proteins (xws li fibrinogen), ua rau cov ntshav viscosity nce ntxiv thiab ua rau muaj kev pheej hmoo ntawm thrombosis. Tsis tas li ntawd, nws thaiv txoj hauv kev NF-κB. Nuclear factor kappa B (NF-κB) yog qhov tseem ceeb ntawm kev hloov pauv kev tswj hwm kev qhia ntawm inflammatory cytokines. Qhov no inhibits qhov ua kom IκB kinase (IKK), txo qhov degradation ntawm IκB, thiab yog li thaiv cov kev hloov pauv ntawm NF-κB, txwv tsis pub hloov pauv ntawm cov noob caj noob ces qis thiab inhibiting inflammatory teb ntawm lawv qhov chaw.
Tswj Coagulation: Epitalon Fibrinolysis System Steady State
Nws tsis cuam tshuam ncaj qha rau txoj hauv kev ua haujlwm tseem ceeb ntawm coagulation yam lossis platelets. Hloov chaw, nws tswj lub cev lub cev neuroendocrine rhythms thiab metabolic tshuav nyiaj li cas los tswj lub zog ruaj khov ntawm cov coagulation thiab fibrinolytic systems ntawm qib holistic, yog li txo qhov kev pheej hmoo ntawm thrombosis. Nws cov txheej txheem tshwj xeeb ntawm kev ua haujlwm tau muab faib ua peb yam hauv qab no:
1. Regulating Melatonin Secretion thiab Restoring Circadian Rhythms ntawm Vascular Tone
Lub secretion atherosclerosis ntawm melatonin los ntawm lub caj pas pineal yog heev synchronized nrog lub voj voog circadian. Kev cuam tshuam ntawm qhov atherosclerosis tuaj yeem cuam tshuam qhov kev hloov pauv ntawm lub cev hauv cov hlab ntsha.Epitalon ntsiav tshuajncaj qha nkoos lub caj pas pineal rau synthesize thiab secrete melatonin, kho circadian atherosclerosis imbalances. Nws cov teebmeem antithrombotic tau tshwm sim hauv ob qhov loj:
Melatonin nws tus kheej muaj cov tshuaj tiv thaiv kab mob antioxidant thiab tiv thaiv - cov haujlwm inflammatory, uas ua rau txo qis oxidative kev nyuaj siab puas tsuaj rau cov hlab ntsha endothelium, txo cov hauv paus pathological rau platelet adhesion.
Melatonin modulates lub contractile muaj nuj nqi ntawm vascular du leeg hlwb, alleviating txawv txav vascular contraction thaum hmo ntuj. Hmo ntuj yog lub sijhawm muaj kev pheej hmoo siab rau cov xwm txheej thrombotic (xws li myocardial infarction thiab cerebral infarction), feem ntau vim cov ntshav khiav qeeb thiab nce vascular nro thaum hmo ntuj, uas ua rau cov ntshav stasis thiab platelet aggregation. Lub rhiab heev secretion ntawm melatonin txhawb vasodilation thiab accelerates nocturnal ntshav txaus, yog li txo qhov kev pheej hmoo ntawm thrombosis los ntawm cov ntshav stasis.
2. Txhim kho qhov sib npaug ntawm cov coagulation-Fibrinolytic System los tswj cov txheej txheem bidirectional Thrombus tsim thiab tawg
Qhov sib npaug dynamic ntawm coagulation thiab fibrinolysis yog qhov tseem ceeb rau kev tswj cov ntshav fluidity. Ib qho kev tsis txaus ntseeg ntawm ob qho tib si tuaj yeem ua rau thrombosis lossis los ntshav. Epitalon tsim ib qho antithrombotic sab hauv ib puag ncig los ntawm bidirectional kev cai ntawm no system:
Inhibiting Coagulation Cascade Activation
Cov kev tshawb fawb preclinical tau lees paub tias nws tuaj yeem txo cov haujlwm ntawm coagulation yam VIII thiab IX hauv ntshav. Coagulation yam VIII thiab IX yog cov khoom tseem ceeb ntawm txoj kev coagulation intrinsic. Kev txo qis hauv lawv cov haujlwm txo qis kev hloov pauv ntawm prothrombin mus rau thrombin, inhibiting coagulation cascade ntawm nws qhov chaw thiab txo qis qhov tshwm sim ntawm lub xeev hypercoagulable.
Txhim kho Endogenous Fibrinolytic Activity
Nws txo qis qhov kev qhia ntawm plasminogen activator inhibitor-1 (PAI-1) thaum txhim kho qib ntawm cov ntaub so ntswg- hom plasminogen activator (t-PA). t-PA yog ib qho tseem ceeb activator ntawm plasminogen, txhawb nws txoj kev hloov mus rau plasmin nquag, thaum PAI-1 tshwj xeeb inhibits t-PA muaj nuj nqi thiab impedes fibrinolysis. Los ntawm kev sib koom ua ke ntawm "upregulating t-PA + downregulating PAI-1," Epitalon accelerates degradation ntawm fibrin hauv lub cev, tiv thaiv kev tsim thiab nthuav ntawm thrombi.
Vascular lipid deposition, tsav los ntawm dyslipidemia, yog lub hauv paus pathological ntawm atherosclerosis. Kev puas tsuaj ntawm cov atherosclerotic plaques tsis ruaj khov yog thawj qhov ua rau mob thrombotic cov xwm txheej. Epitalon siv cov kev tswj hwm dej ntws ntawm cov hlab ntsha los ntawm kev txhim kho lipid metabolism profiles:
Nws txo qis cov roj cholesterol tag nrho, triglycerides, thiab qis -cov roj lipoprotein ceev (LDL-C). LDL-C yog qhov tseem ceeb lipoprotein lub luag haujlwm rau lipid infiltration mus rau vascular endothelium. Kev txo qis hauv nws cov qib txo qis lipid deposition nyob rau hauv subendothelial txheej ntawm cov hlab ntsha, slowing lub tsim thiab kev loj hlob ntawm atherosclerotic plaques.
Los ntawm inhibiting plaque kev loj hlob,Epitalon ntsiav tshuajtxo qhov nthuav dav ntawm cov lipid core thiab thinning ntawm cov fibers cap nyob rau hauv cov quav hniav, txhim kho cov quav hniav ruaj khov thiab txo txoj kev pheej hmoo ntawm cov quav hniav. Thaum cov plaque ruptures, procoagulant tshuaj nyob rau hauv cov quav hniav raug mus rau hauv cov hlab ntsha, sai sai triggering platelet aggregation thiab ua kom cov coagulation cascade, ua rau mob thrombosis. Los ntawm kev tswj cov plaque stability, nws hais txog lub hauv paus ua rau, txo qhov tshwm sim ntawm mob thrombotic xwm txheej.
Xaus
Nyob rau hauv cov ntsiab lus, raws li ib tug hluavtaws tetrapeptide (amino acid sequence Ala-Glu-Asp-Gly, AEDG), cov tshuaj no siv ntau yam biological functions nyob rau hauv kev tswj lub cev homeostasis los ntawm nws multi- hom phiaj, multi-kauj ruam cov yam ntxwv. Cov haujlwm no suav nrog ncua kev laus ntawm cov cellular, tiv thaiv vascular endothelium, tswj kev sib npaug ntawm neuroendocrine, thiab txhim kho cov metabolism hauv homeostasis, thiab lwm yam. Ntawm nws cov txiaj ntsig zoo, nws lub luag haujlwm hauv kev txo qis kev pheej hmoo ntawm thrombosis sawv tawm - nws tsis cuam tshuam ncaj qha rau txoj hauv kev tseem ceeb ntawm coagulation lossis platelet activation. Hloov chaw, nws tsim ib qho kev tiv thaiv kev tiv thaiv kab mob thrombosis los ntawm kev khaws cov vascular endothelial kev ncaj ncees, optimizing hemorheological zog, inhibiting oxidative kev nyuaj siab thiab inflammatory teb, thiab tswj lub homeostasis ntawm lub coagulation{10}}fibrinolytic system los ntawm indirect txoj kev. Qhov no muaj cov tswv yim pab cuam tshiab rau kev tiv thaiv thrombosis, tshwj xeeb tshaj yog rau cov hnub nyoog - cuam tshuam thiab endothelial puas tsuaj - ntsig txog thrombosis.
Txawm hais tias kev tshawb fawb tam sim no ntawm Epitalon tseem muaj qee qhov kev txwv -xws li qhov xav tau nthuav dav ntawm cov ntaub ntawv pov thawj kho mob thiab txuas ntxiv ua kom ntev ntev -cov ntaub ntawv kev nyab xeeb- kev nce qib hauv kev tshawb fawb thev naus laus zis yuav ua rau nkag siab tob txog nws cov txheej txheem thiab kev siv dav dav. Nyob rau hauv lub neej yav tom ntej, kev txhawb nqa los ntawm ntau qhov loj - nplai, ntau-cov kev tshawb fawb hauv chaw kho mob, nws yuav tsum ua kom muaj kev cuam tshuam ntau dua hauv kev tiv thaiv -thrombosis thiab txawm nyob rau hauv dav dav xws li tiv thaiv- kev laus thiab kev tiv thaiv kab mob ntev, nqa cov txiaj ntsig tshiab thiab muaj peev xwm tiv thaiv tib neeg kev noj qab haus huv.
Cim npe nrov: Tuam Tshoj epitalon capsule manufacturers, lwm tus neeg
